Movement Disorders Clinical Trial
Official title:
Effectiveness of a Wheelchair Skills Training Program for Power Mobility Users: A Randomized Controlled Trial
Verified date | May 2016 |
Source | Nova Scotia Health Authority |
Contact | n/a |
Is FDA regulated | No |
Health authority | Canada: Health Canada |
Study type | Interventional |
This is a 3-year multi-centre, single-blinded, randomized controlled trial (RCT) to test the hypothesis that wheelchair skills training (using a systematic training program called the Wheelchair Skills Training Program) improves wheelchair skills and safety of 144 powered wheelchair users. A second objective is to assess the effects of age, sex, training centre, and participant experience on outcomes, assessing the retention of benefits and assessing the impact of training on other important outcomes.
Status | Completed |
Enrollment | 116 |
Est. completion date | September 2014 |
Est. primary completion date | September 2014 |
Accepts healthy volunteers | No |
Gender | Both |
Age group | 18 Years and older |
Eligibility |
Inclusion Criteria: - new or experienced powered wheelchair users - use or are expected to use powered wheelchairs for at least 4 hrs/week - have access to a powered wheelchair with a suitable range of controller settings (i.e. able to climb a 5cm level change) for testing and training - equal or greater than 18 years of age - able to follow directions in either French or English (whichever is in use at the participating site) - have the potential to operate their powered wheelchairs independently - have room for improvement (in the opinion of the potential participant's clinician) - requires no more than minimal assistance for communication and auditory comprehension (in the opinion of the potential participant's clinician) - able to follow 2-step commands - demonstrate the ability to attend training sessions during the intake session - competent to provide their own informed consent - able to be comfortably seated in the powered wheelchairs that will be used for the study (if not their own). Exclusion Criteria: - use or are expected to use a scooter - have a rapidly progressive disorder (e.g. amyotrophic lateral sclerosis or terminal cancer) - have significant visual impairments (legally blind) - have unstable medical conditions (e.g. angina, seizures) - have emotional problems (e.g. severe anxiety, depression) that might make participation unsafe or unpleasant |
Allocation: Randomized, Intervention Model: Parallel Assignment, Masking: Single Blind (Outcomes Assessor), Primary Purpose: Supportive Care
Country | Name | City | State |
---|---|---|---|
Canada | Nova Scotia Rehabilitation Centre | Halifax | Nova Scotia |
Canada | University of Western Ontario | London | Ontario |
Canada | Centre de Réadaptation Lucie-Bruneau | Montreal | Quebec |
Canada | Centre Interdisciplinaire de Recherche en Réadaptation et Intégration Sociale | Quebec City | Quebec |
Canada | Toronto Rehab | Toronto | Ontario |
Canada | GFS Rehabilitation Centre | Vancouver | British Columbia |
Lead Sponsor | Collaborator |
---|---|
Nova Scotia Health Authority | Canadian Institutes of Health Research (CIHR) |
Canada,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Change from baseline in Wheelchair Skills, WST 4.1 questionnaire version | A measure of what the person 'can do' (capacity), 'does do' (performance), and the safety of various wheelchair skills. The Wheelchair Skills Test (WST) version 4.1 in questionnaire format will be used. | baseline, 1 month , 3 months | Yes |
Status | Clinical Trial | Phase | |
---|---|---|---|
Active, not recruiting |
NCT05623644 -
Multimodal MR Imaging Study on ET and PD Patients Subjected With MRgFUS Thalamotomy
|
||
Active, not recruiting |
NCT03548779 -
North Carolina Genomic Evaluation by Next-generation Exome Sequencing, 2
|
N/A | |
Completed |
NCT03295786 -
Clinical Study to Test the Safety of CDNF by Brain Infusion in Patients With Parkinson's Disease
|
Phase 1/Phase 2 | |
Completed |
NCT03722212 -
Early Diagnosis of the GLUT1 Deficiency Syndrome With a Blood Based Test
|
N/A | |
Recruiting |
NCT05973929 -
Movement Disorders in Multiple Sclerosis Patients
|
||
Terminated |
NCT02823158 -
Bilateral Pallidal Stimulation in Patients With Advanced Parkinson's Disease-LATESTIM
|
N/A | |
Enrolling by invitation |
NCT01210781 -
Target Planning for Placement of DBS-electrodes and Follow-up of the Clinical Efficacy of Stimulation
|
||
Enrolling by invitation |
NCT00355927 -
Sedation During Microelectrode Recordings Before Deep Brain Stimulation for Movement Disorders.
|
N/A | |
Completed |
NCT00037167 -
Effects of Exercise Poles on Older Adults During Exercise Walking
|
Phase 1/Phase 2 | |
Recruiting |
NCT04784494 -
MST for Parkinson's Disease
|
N/A | |
Terminated |
NCT03270189 -
Effect of the Visual Information Change in Functional Dystonia
|
N/A | |
Recruiting |
NCT04176692 -
The Effects of Muscle Characteristics on the Control of Shoulder Complex During Functional Movements
|
||
Recruiting |
NCT04061135 -
Neurophysiological, Behavioral, and Cognitive Networks in Movement Disorders
|
N/A | |
Suspended |
NCT04912115 -
Randomized, Double-Blind, Active Placebo-Controlled Study of Ketamine to Treat Levodopa-Induced Dyskinesia
|
Phase 2 | |
Completed |
NCT00500994 -
Neurobiology of Functional Movement Disorder and Non-Epileptic Seizures
|
Early Phase 1 | |
Completed |
NCT04536987 -
Robot Therapy for Rehabilitation of Hand Movement After Stroke
|
Phase 2 | |
Recruiting |
NCT00001208 -
Botulinum Toxin for the Treatment of Involuntary Movement Disorders
|
||
Completed |
NCT02392078 -
Laser Ablation of Abnormal Neurological Tissue Using Robotic NeuroBlate System
|
||
Completed |
NCT00552474 -
Deep Brain Stimulation to Treat Symptoms of Parkinson's Disease
|
N/A | |
Not yet recruiting |
NCT05032911 -
Sensorimotor Control in People With and Without Neck Pain
|